Intervention Condition for COVID-19 Vaccination

UMass Chan Medical School, Worcester, MA
COVID-19 VaccinationCONFIDENCE - Behavioral
All Sexes

Study Summary

This trial will test an intervention to increase COVID-19 vaccine intention in parents of under-vaccinated children. Clinics will receive webinar training, materials, and posters to help communicate with vaccine-hesitant parents.

Eligible Conditions
  • COVID-19 Vaccination

Treatment Effectiveness

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: End of study; approximately 15 months

Data collection will occur in the four weeks following implementation
COVID-19 vaccine intention
Month 15
Feasibility: Data Completeness
Feasibility: Randomization
Feasibility: Recruitment
Four to eight weeks post implementation
Acceptability: Parents
Acceptability: Providers and clinic staff
Implementation Fidelity
Perceived Appropriateness: Providers and clinic staff
Perceived appropriateness: Parents
Perceived feasibility: Providers and clinic staff

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Waitlist Condition
1 of 2
Intervention Condition
1 of 2

Active Control

Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention Condition · No Placebo Group · N/A

Intervention Condition
Experimental Group · 1 Intervention: CONFIDENCE · Intervention Types: Behavioral
Waitlist Condition
ActiveComparator Group · 1 Intervention: CONFIDENCE · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: end of study; approximately 15 months

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
318 Previous Clinical Trials
754,882 Total Patients Enrolled
Merck Sharp & Dohme LLCIndustry Sponsor
3,737 Previous Clinical Trials
4,973,499 Total Patients Enrolled
Baystate HealthOTHER
5 Previous Clinical Trials
52,496 Total Patients Enrolled
Stephenie C Lemon, PhDPrincipal InvestigatorUniversity of Massachusetts Chan Medical School

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any open enrolment slots for this research project?

"Indeed, the website shows that this medical trial is still recruiting patients since it was first published on March 27th 2023 and last revised on May 5th of the same year. 400 individuals need to be recruited from one particular site for this study." - Anonymous Online Contributor

Unverified Answer

What is the current participant count for this clinical experiment?

"Affirmative. According to, this research project is still recruiting participants who applied after the initial posting on March 27th 2023 and before the last update on May 5th 2023. 400 people are required across 1 centre for successful completion of this study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.